Larvol Delta - Blue-Earth-Therapeutics-announces-rst-participant-dosed-in-Phase-1-clinical-trial-investigating-Actinium-178178Ac-rhPSMA101-Injection-in-metastatic-castrationresistant-prostate-cancer

225Ac-rhPSMA-10.1 - Blue Earth Therapeutics

https://www.prnewswire.com/news-releases/blue-earth-therapeutics-announces-first-participant-dosed-in-phase-1-clinical-trial-investigating-actinium-ac-rhpsma-10-1-injection-in-metastatic-castration-resistant-prostate-cancer-302820625.html

Jul 9, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next